$295 Million is the total value of Tavio Capital LLC's 17 reported holdings in Q2 2018. The portfolio turnover from Q1 2018 to Q2 2018 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| RTRX | RETROPHIN INC | $8,012,000 | +21.9% | 293,923 | 0.0% | 2.71% | -12.5% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-08-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MOLINA HEALTHCARE INC | 13 | Q2 2020 | 29.6% |
| CENTENE CORP DEL | 11 | Q2 2020 | 19.1% |
| ANTHEM INC | 10 | Q2 2019 | 22.5% |
| BOSTON SCIENTIFIC CORP | 9 | Q4 2019 | 20.9% |
| RETROPHIN INC | 9 | Q1 2019 | 3.4% |
| ZIMMER BIOMET HOLDINGS INC | 8 | Q2 2020 | 20.6% |
| HUMANA INC | 8 | Q4 2019 | 37.8% |
| UNIVERSAL HLTH SVCS INC | 8 | Q1 2019 | 14.7% |
| HCA HEALTHCARE INC | 8 | Q1 2020 | 12.3% |
| MCKESSON CORP | 7 | Q2 2020 | 23.1% |
View Tavio Capital LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2020-10-01 |
| 13F-HR | 2020-08-13 |
| 13F-HR | 2020-05-14 |
| 13F-HR | 2020-02-13 |
| 13F-HR | 2019-11-13 |
| 13F-HR | 2019-08-13 |
| 13F-HR | 2019-05-14 |
| 13F-HR | 2019-02-14 |
| 13F-HR | 2018-11-13 |
| 13F-HR | 2018-08-13 |
View Tavio Capital LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.